Request Demo
Last update 25 Apr 2025
[67Cu]Cu-MeCOSAR-Tz
Last update 25 Apr 2025
Overview
Basic Info
Drug Type Diagnostic radiopharmaceuticals, Radionuclide Drug Conjugates (RDC), Therapeutic radiopharmaceuticals + [1] |
Synonyms- |
Target |
Action inhibitors |
Mechanism GPA33 inhibitors(Cell surface A33 antigen inhibitors), PSMA inhibitors(Prostate-specific membrane antigen inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Structure/Sequence
Boost your research with our ADC technology data.
login
or
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| HER2 Positive Breast Cancer | Preclinical | Australia | 27 Apr 2025 | |
| Pancreatic Ductal Adenocarcinoma | Preclinical | United States | 09 Apr 2024 | |
| Pancreatic Ductal Adenocarcinoma | Preclinical | United States | 09 Apr 2024 | |
| Pancreatic Ductal Adenocarcinoma | Preclinical | Australia | 09 Apr 2024 | |
| Pancreatic Ductal Adenocarcinoma | Preclinical | Australia | 09 Apr 2024 | |
| Prostatic Cancer | Preclinical | United States | 09 Apr 2024 | |
| Prostatic Cancer | Preclinical | United States | 09 Apr 2024 | |
| Prostatic Cancer | Preclinical | Australia | 09 Apr 2024 | |
| Prostatic Cancer | Preclinical | Australia | 09 Apr 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free